丹纳赫2024Q4:稳定、强劲但不完美

循因缉药
04 Feb

各位亲爱的股东,大家早上好中午好晚上好。今天,我们来看下2024Q4丹纳赫Danaher的表现。作为LSRT领域的巨头,丹纳赫对于整个行业来说都具有极强的借鉴意义。我们仍然将从3个方面入手进行探讨:第一,业绩是否如预期?第二,中国区表现如何?第三,关于未来Danaher丹纳赫有什么预期?#01稳定、强劲2025年1月29日,生命科学巨头Danaher丹纳赫发布财报。财报显示,2024Q4公司营收...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10